Does neoadjuvant versus adjuvant systemic treatment improve outcomes in breast cancer?

被引：2
作者：
Roukos, DH [1 ]
Kappas, AM [1 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Surg, Surg Oncol Res Unit, GR-45110 Ioannina, Greece
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2005年 / 2卷 / 07期
关键词：
adjuvant treatment; breast cancer; neoadjuvant therapy;
D O I：
10.1038/ncponc0222
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：342 / 343
页数：2
相关论文
共 6 条
  • [1] Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: Results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
    Buzdar, AU
    Ibrahim, NK
    Francis, D
    Booser, DJ
    Thomas, ES
    Theriault, RL
    Pusztai, L
    Green, MC
    Arun, BK
    Giordano, SH
    Cristofanilli, M
    Frye, DK
    Smith, TL
    Hunt, KK
    Singletary, SE
    Sahin, AA
    Ewer, MS
    Buchholz, TA
    Berry, D
    Hortobagyi, GN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3676 - 3685
  • [2] Chemotherapy: What progress in the last 5 years?
    Hamilton, A
    Hortobagyi, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1760 - 1775
  • [3] Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
    Mauri, D
    Pavlidis, N
    Ioannidis, JPA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03): : 188 - 194
  • [4] Estrogen-receptor biology: Continuing progress and therapeutic implications
    Osborne, CK
    Schiff, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1616 - 1622
  • [5] Perspectives and risks of breast-conservation therapy for breast cancer
    Roukos, DH
    Kappas, AA
    Agnantis, NJ
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (07) : 718 - 721
  • [6] Gene expression profiling of breast cancer: A new tumor marker
    van't Veer, LJ
    Paik, S
    Hayes, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1631 - 1635
1